CRISPR Used to Increase Glucoraphanin Content in Chinese KaleMay 24, 2023
Plant secondary metabolite glucoraphanin (GRA) generates a hydrolysis product that has potent anticancer activity. GRA is available in Chinese kale but only in trace amounts. To improve the GRA content of Chinese kale, three copies of the ALKENYL HYDROXALKYL PRODUCING 2 (AOP2) gene were isolated and edited using the CRISPR-Cas9 system. This led to boaaop2 mutants with increased levels of GRA. It was also observed that the expression of upstream genes of glucosinolate biosynthesis was decreased in the mutants.
Based on the findings, the researchers pinpoint BoaAOP2.1 as an effective gene for the alkenylation of aliphatic glucosinolates.
Read the research article in Food Research International.
You might also like:
- Researchers Apply Gene Editing in Chinese Kale
- Researchers Develop Bacon-flavored Superfood Seaweed
- Scientists Discover One-Step Genome Editing Technique that Accelerates Seed Breeding
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
Research and Tools
- CRISPR Used to Increase Glucoraphanin Content in Chinese Kale
- CRISPR Leafy Greens Now Available in US Market
- Proprietary CRISPR Technology Accelerates Innovation in Agriculture Products, Supply Chains, and Production Systems
Policy Considerations and Approvals
- Canada Updates Guidance To Promote Transparency of Gene Editing Regulatory Process
- EU MEP Says New Genetic Techniques to Innovate Farming and Help to Adapt to Climate Change
Trends and Impact
- Global Gene Editing Technologies Market Size And Forecast
Read the latest:
- Biotech Updates (September 27, 2023)
- Gene Editing Supplement (September 27, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: